Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in FILANA THERAPEUTICS INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC previously held 0 shares of SAVA (FILANA THERAPEUTICS INC), worth $0 as of 2025-Q2.
Final Value
$0
Final Shares
0
Total Value Change
-$913,519
Total Shares Change
-73,969
Other major holders of SAVA: BNP PARIBAS FINANCIAL MARKETS
Exited |
| 0 |
-100.0% |
| $0 |
| 0.0% |
| $1.75 |
0 |
| 2025-Q1 | Decreased | 17,424 | -76.8% | $26,136 | 0.0% | $1.65 | 0 |
| 2024-Q4 | Increased | 75,084 | +23.3% | $177,198 | 0.0% | $2.40 | 19 |
| 2024-Q3 | Decreased | 60,894 | -17.7% | $1.8M | 0.0% | $28.49 | 0 |
| 2024-Q2 | Increased | 73,969 | +59.8% | $913,519 | 0.0% | $12.35 | 36 |